AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

Delisting risk

HYPR · NASDAQ · Medical - Devices

Hyperfine

Makes and supports Swoop, a portable ultra-low-field brain-MRI system.

$0.8310

After-hours close−0.00 (−0.23%)

At close$0.8329(−1.48%)

Something off on this page? Send us feedback.

Profile

Hyperfine, Inc.HYPRHealth Care

Swoop combines portable ultra-low-field MRI hardware, Optive AI image-reconstruction software, and field service for brain imaging. It is Hyperfine's sole reportable business, sold through a direct organization focused on U.S. hospitals and neurology settings.

Founded in 2014, the company now centers its operations entirely on Swoop, a portable ultra-low-field MR system for brain imaging. It produces, supplies, services, and commercializes the system as its sole reportable business.

Next-generation Swoop hardware pairs with Optive AI image-reconstruction software. FDA clearance covers brain imaging across patients of all ages, following its initial U.S. brain-imaging clearance.

Commercialization initially focused on U.S. hospital and hospital-system contracts, then extended to emergency departments, hospital-based neurology clinics, and neurology offices. A direct sales and field-support organization supports the commercial single-system platform across these care settings.

Company facts

CEOMaria Sainz

ListedDec 23, 2021

ExchangeNASDAQ

HeadquartersGuilford, CT

CountryUnited States

Employees102

CIK0001833769

ISINUS44916K1060

Key statistics

Market cap$70.2M

EPS (ttm)−$0.3828

P/E (ttm)−2.18

ROE-100.3%

P/B2.26

P/S4.24

Dividend yield—

Beta2.37vs XLV −0.39

Year to date −14.1% · Average volume (30d) 579.7K

Analysts

Price target, next 12 months$2.00+141.0%Median of 4 analysts · vs the Aug 28 close

ConsensusBuy3 of 4 analysts rate it buy or better

Ratings

Strong buyBuyHoldSellStrong sell

Target range

Last close $0.8300

High$2.00+141.0%

Median$2.00+141.0%

Low$2.00+141.0%

12 months agoNowIn 12 months

Latest analyst notes

Date	Firm	Action	Rating	Target
Aug 20, 2026	BTIG	Reiterate	Buy	$2

Earnings

EPS

Estimate−$0.08

ReportedDue Nov 12, 2026

Revenue

Estimate$5.1M

ReportedDue Nov 12, 2026

History

Report date	EPS est	EPS	Surprise	Revenue est	Revenue	Surprise	Next session
Aug 6, 2026Q2 FY26	−$0.09	−$0.09	0.0%	$4.1M	$3.9M	−5.6%	−2.75%
May 12, 2026Q1 FY26	−$0.09	−$0.09	0.0%	$3.5M	$3.9M	+10.3%	−8.09%
Mar 18, 2026Q4 FY25	−$0.08	−$0.08	0.0%	$5.2M	$5.3M	+2.7%	−4.72%
Nov 13, 2025Q3 FY25	−$0.10	−$0.11	−10.0%	$5.3M	$3.4M	−35.2%	+9.52%

View details

Financial highlights

	Q1 FY25	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26
Revenue	$2.1M	$2.7M	$3.4M	$5.3M	$3.9M	$3.9M
Gross profit	$883.0K	$1.3M	$1.8M	$2.7M	$2.0M	$2.0M
Operating income	−$10.9M	−$9.6M	−$8.9M	−$7.7M	−$8.6M	−$8.5M
Net income	−$9.4M	−$9.2M	−$11.0M	−$5.9M	−$8.6M	−$9.3M
Diluted EPS	−$0.12	−$0.12	−$0.14	−$0.06	−$0.09	−$0.09
Gross margin	41.3%	49.3%	53.8%	50.9%	50.7%	50.7%
Operating margin	-510.2%	-355.9%	-259.5%	-144.9%	-219.3%	-216.9%

Fiscal years (4-quarter sums)FY21 $1.5M · FY22 $6.8M · FY23 $11.0M · FY24 $12.9M · FY25 $13.6M

Revenue by product · Q2 FY26

Product$3.2M · 81%

Service$734.0K · 19%

Revenue by geography · Q2 FY26

Non-US Countries$1.2M · 100%

Balance sheet, Jun 30, 2026Cash & short-term investments $43.5M · Total debt $13.4M · Total assets $63.0M · Shareholders' equity $36.8M

Dividends

No dividends on record.

Ownership

Institutions 16.59%13.97M sharesInsiders 2.44%2.05M sharesOther 80.97%68.19M shares

Shares outstanding 84.22M · Float 66.55M · 79.0% free float

Top shareholders13F · 13D/G · Form 4

Holder	Shares	% outstanding	Form	Filed
BlackRock, Inc.	4.67M	5.50%	13G	Jul 28, 2026
Vanguard Capital Management LLC	3.45M	4.10%	13F	May 15, 2026
Fosun International Ltd	1.74M	2.07%	13F	May 14, 2026
Catalio Capital Management, LP	1.32M	1.57%	13F	May 15, 2026
Sio Capital Management, LLC	1.00M	1.19%	13F	May 14, 2026

Insider tradesForm 4

Date	Insider	Role	Shares	Avg price
Aug 24, 2026	Brett Hale	officer: CFO and CAO	−7,345	$0.8540
Aug 24, 2026	Thomas Teisseyre	officer: Chief Operating Officer	−7,345	$0.8540
May 26, 2026	Thomas Teisseyre	officer: Chief Operating Officer	−6,047	$1.65
May 26, 2026	Brett Hale	officer: CFO and CAO	−6,047	$1.65
Mar 23, 2026	Brett Hale	officer: CFO and CAO	−24,188	$1.21